Prot # JVS-100: STOP-PAD: A Phase 2B Randomized Double-Blind, Placebo Controlled - Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as adjunct to revascularization of infrapopliteal lesions in subjects wi

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/16 → 1/1/19

Funding

  • Juventas Therapeutics, Inc. (Prot # JVS-100)